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Splenectomy in Liver Cirrhosis 
with Splenomegaly and 
Hypersplenism
Adianto Nugroho
Abstract
Spleen is a “mysterious” organ since with unique functions, and might be related 
to other pathology in the human body. Splenomegaly and hypersplenism can mani-
fest following the development of portal hypertension in liver cirrhosis through 
fibrogenesis, immune and microenvironment dysregulation. Cirrhotic patients are 
generally considered as immunocompromised and prone to infections. Splenectomy 
in cirrhotic patients has produced concern over decrease immunity and elevated 
risk of infection, namely overwhelming post splenectomy pneumococcal sepsis. 
This review discus the splenectomy effect to the liver and how it can play a role in 
cirrhotic patients with portal hypertension without readily available access to liver 
transplantation.
Keywords: splenectomy, liver cirrhosis, hypersplenism, splenomegaly, 
liver transplantation
1. Introduction
The spleen is a unique organ with many functions, including its crosstalk with 
the liver in cirrhotic patients. This review aims to answer a clinical question “Should 
splenectomy be done in liver cirrhosis with hypersplenism and splenomegaly?” .
2. The spleen
The spleen is an organ full of mystery, as stated by Galen. From the ancient times 
until the Renaissance, descriptions of the gross anatomy of the spleen were rela-
tively accurate, yet the physiology of this organ remains incomplete and inaccurate. 
Even until today, much of spleen’s function are still yet to be discovered [1].
Spleen comprised of two distinct compartments, both functional and mor-
phological, namely red pulp and white pulp. The red pulp filters blood to remove 
foreign material and damaged erythrocytes. It also serves as iron, erythrocytes 
and platelets storages. With one fourth of body’s lymphocytes stores in the spleen, 
it is the largest secondary organ which initiate immune response to blood-borne 
antigens [2]. It exerts important effects on local and systemic immune responses, 
which have the potential to affect different tissues and organs [3]. The white pulp, 
composed by periarteriolar lymphoid sheath (PALS), the follicles and the marginal 
zones, are the one responsible for this so called immune functions [2].
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In addition, the spleen also produces opsonins, a substances that bind to 
the  foreign antigen, which in turn enhance their uptake and phagocytosis by 
macrophages. Furthermore, the B-lymphocytes within the germinal centers of the 
spleen are also sites for the production of antibody activated by foreign antigen. 
The realization of this important immunological function has promoted the desire 
for splenic  preservation [4].
3. Liver cirrhosis and the spleen
The association between the liver and spleen are shown in three different catego-
ries. Both organ, anatomically important in the portal circulation. Histologically, 
they share similar possession of reticuloendothelial structures, participating in 
substance exchange and cellular migration. And immunologically, both organs plays 
essential roles in immune homeostasis and pathogen clearance [2].
The first recorded encounter between spleen and cirrhosis could be trace back 
to Carl Freiderich Quittenbaum (1793–1852) of Rostock, Germany, who removed 
the spleen of a woman with cirrhosis and ascites “more from the patient’s urgent 
entreaty rather than the surgeon’s judgment.” Unfortunately the woman lived only 
6 h after the surgery [5].
The palpable spleen has long been considered as an obvious signs of liver 
cirrhosis, frequently occurs in parallel with hypersplenism, to be the major cause 
of cytopenia and thrombocytopenia. This condition are relatively sub-fatal, even 
in the absence of a bleeding varices. During the progression of liver cirrhosis, the 
spleen-derived immune cells and cytokines may travel into the injured liver via 
portal blood flow. Together with the portal hypertension and congestion, this will 
result in splenomegaly and hypersplenism. Furthermore, the chemokines, DAMPs 
like HMGB1, or exosomes, are also release into the circulation, which will trigger 
the activation and/or migration of splenocytes. This mechanism are known as the 
liver and spleen crosstalk pathways during liver cirrhosis [2].
Spleen size in patients with cirrhosis varies by the etiology of the disease. While 
in healthy adults, the size of the spleen in usually less than 12 cm, in cirrhotic 
patients it is relatively larger, as shown in the study by Kashani et al. This study 
revealed that the mean spleen size in the alcohol group (13.1 ± 2.5 cm) was signifi-
cantly smaller than in the hepatitis C (15.0 ± 3.4 cm) and nonalcoholic steatohepa-
titis (15.2 ± 3.0 cm) groups (95% confidence intervals of the mean difference, 0.6 to 
3.3 and 0.8 to 3.4 cm, respectively), sonographically [6].
4. Splenectomy effects to the liver
Cirrhotic patients are generally considered as immunocompromised, mainly 
due to the development of bacterial infection and community-acquired infections. 
Since the spleen is the largest lymphoid organs with large amount of T and B cells, 
macrophages, and dendritic cells, splenectomy in cirrhotic patients has produced 
concern over decrease immunity and elevated risk of infection, namely overwhelm-
ing post splenectomy pneumococcal sepsis.
However, a study by Hirakawa et al., showed the possibility of reducing suppres-
sive cell fractions and enhancement of the effector cell population and functions 
by means of splenectomy, thus ameliorate the impaired immune status of cirrhotic 
patients [7].
Yamada et al. demonstrated that splenectomy improved hepatic  functional reserves 
and nutritional metabolism, together with improvement in thrombocytopenia and 
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leukopenia in cirrhotic patients. Splenectomy is thought to induce a decrease in plate-
let pooling or breakdown in the spleen of thrombocytopenic patients, and as a result, 
increase blood platelet counts. Bilirubinemia secondary to hypersplenism, which is 
caused by an increase in bilirubin production, that overloads the capacity of the liver 
to metabolize bilirubin, are also reduced after splenectomy [8].
In a study by Ueda et al. of rats undergoing major liver resection with or without 
splenectomy, early stage splenic red pulp TGF-β1 production and secretion into the 
portal blood exert an inhibitory effect on liver regeneration. Splenectomy reversed 
this inhibition and enhanced the regeneration of hepatocytes [9].
Study by Huang et al., unveiled serum cytokine profiles in HBV-related cirrhosis 
patients with PH and hypersplenism, indicating a potential role of the hypertensive 
spleen in the progression of liver disease. Furthermore, the changes in cytokine 
levels following splenectomy maybe potential advantageous to reduce liver fibrosis 
and accelerate liver regeneration as well as reduce the risk of HCC [10].
Splenectomy also enhanced the repopulation of adoptively transferred bone 
marrow cell in cirrhotic liver and decreased collagen deposition through the upregu-
lation of MM9 expression in transferred bone marrow cells, as suggested by Iwamoto 
et al. [11], and improved the efficiency of adipose tissue-derived mesenchymal cell 
transplant into the liver by enhancing liver SCF-1 and HGV expressions [12].
Considering all of the above mention mechanism, targeting spleen for the 
 treatment of liver cirrhosis can be achieved through [2]:
• amelioration of cirrhosis’ fatal complications such as bleeding esophageal or 
gastric varices
• efficiently improving liver function and the prognosis of esophageal varices
• increasing the efficacy of liver transplantation and improving the prognosis 
of HCC
• supplementary treatment for anti-HCV therapy in combination with 
 interferons and other pharmaceuticals
5.  Technical and perioperative consideration for splenectomy in 
cirrhotic liver
Surgery in a patient with liver disease carries specific and higher risks, compare 
to those with normal populations. Perioperative care including assessment and opti-
malization is the key to a safe surgery. Many cirrhosis patients present themselves 
with a relative contraindications that preclude surgery.
The predictors for complications including Child-Pugh class B or C, ascites, 
etiology of cirrhosis other than PBC, elevated creatinine, preoperative  infection, 
COPD, preoperative upper GI bleeding, invasiveness of surgical procedure, intraop-
erative hypotension, and ASA status 4–5. While the predictors of mortality including 
male gender, Child-Pugh class B or C, ascites, etiology of cirrhosis other than PBC, 
preoperative infection, ASA status 4–5 and respiratory surgery. The presence of 1 risk 
factors carries a 9.3% risk of complications, and this increase with the more numbers 
of risk factors. A total of 7–8 risk factors carries a 100% risk of  complications [13].
Friedman proposed the following list of contraindication to elective surgery 
in patients with liver disease, including acute viral hepatitis, alcoholic  hepatitis, 
acute liver failure, acute renal failure, severe coagulopathy, hypoxemia and 
 cardiomyopathy [14].
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Regarding the preferred method for splenectomy, recently laparoscopic has 
become technically feasible, safe and effective procedure for hypersplenism second-
ary to cirrhosis, and contributes to less blood loss, shorter length of stay and less 
impairment of liver function. However, this methods are generally more costly 
and might not readily available in every hospital. Thus the choice of splenectomy 
method must be personally selected for each patient, surgeon and hospital [15].
6. Splenectomy as a bridge to liver transplant
It is already a general consensus that liver transplantation is the preferred treat-
ment options for patient with end stage liver disease. However, the waiting time for 
liver transplantation is also long due to the shortage of donor organs, even in living 
donor liver transplantation setting. Moreover, in some countries, liver transplanta-
tion still not a feasible option for all patients.
One among many alternatives is by doing a splenectomy prior to liver transplan-
tation in patient with liver cirrhosis and subsequent splenomegaly-hypersplenism. 
A study by Kong et al., studied 833 patient patients underwent liver transplanta-
tion, of which 88 patients had splenectomy before liver transplantation. They 
found that postoperative infection and 90-days mortality in the splenectomy and 
non-splenectomy group were not statistically difference. Furthermore, the post-
transplant thrombocytopenia and early allograft dysfunctions is significantly lower 
in splenectomy group compare to non-splenectomy group. They suggested that pre-
transplantation splenectomy is recommended in cases with risky patients without 
appropriate source of liver for LT. Taking into consideration the possibility of more 
difficult operation due to adhesion when transplantation is being done. One thing 
to note is that as a “re-operation” the splenectomy is often as- sociated with more 
difficult dissection due to adhesions [16].
7. Summary
Splenectomy is beneficial in reversal of the pathologic process through live 
regeneration and pre-transplant splenectomy could be an alternative in patients 
without appropriate source of liver for liver transplantation. However, perioperative 
considerations should be thoroughly assessed to allow a safe surgery.
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